Ann: Updates regarding Aqua Phase Delivery Technology, page-6

Company is very undervalued at these prices imo - I suspect a successful Schedule 3 trial would put a rocket up this as it derisks the lack of near term revenue growth potential until Aquaphase is properly commercialised (although even if successful that won’t be making money until 2024 most likely either). I’m not holding my breath given the other results in this space but I’m quietly confident based on discussions with the company indicating that they are fully aware of the shortcomings of these trials. Hopefully we’ve done something different!

Keen to get further detail on the potential commercial partnerships using Aquaphase in the meantime as well.